Joe Shan

Learn More
Antibody-mediated blockade of phosphatidylserine enhances the anti-tumor activity of targeted therapy and immune checkpoint inhibitors by affecting myeloid and lymphocyte populations in the tumor microenvironment The underlying cause for the failure of immune checkpoint blockade is the overwhelming, persistent and multifo-cal immune suppression in the tumor(More)
  • 1